Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Feb 28:10:1144849.
doi: 10.3389/fcvm.2023.1144849. eCollection 2023.

Editorial: Emerging roles of miRNAs in cardiovascular disease

Donato Santovito  1   2   3 , Yuhua Fan  4 , Leonardo Elia  5   6 , Joanne T M Tan  7   8 , Emiel P C van der Vorst  1   2   9
Affiliations
Editorial

Editorial: Emerging roles of miRNAs in cardiovascular disease

Donato Santovito et al. Front Cardiovasc Med. .
No abstract available

Keywords: acute coronary syndrome; biomarker; cardiovascular disease; macrophages; miRNA.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

    1. Bartel DP. Metazoan MicroRNAs. Cell. (2018) 173:20–51. 10.1016/j.cell.2018.03.006 - DOI - PMC - PubMed
    1. Peters LJF, Biessen EAL, Hohl M, Weber C, van der Vorst EPC, Santovito D. Small things matter: relevance of MicroRNAs in cardiovascular disease. Front Physiol. (2020) 11:793. 10.3389/fphys.2020.00793 - DOI - PMC - PubMed
    1. Yang WJ, Yang DD, Na S, Sandusky GE, Zhang Q, Zhao G. Dicer is required for embryonic angiogenesis during mouse development. J Biol Chem. (2005) 280:9330–5. 10.1074/jbc.M413394200 - DOI - PubMed
    1. Santovito D, Weber C. Non-canonical features of microRNAs: paradigms emerging from cardiovascular disease. Nat Rev Cardiol. (2022) 19:620–38. 10.1038/s41569-022-00680-2 - DOI - PubMed
    1. Taubel J, Hauke W, Rump S, Viereck J, Batkai S, Poetzsch J, et al. Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human phase 1b randomized, double-blind, placebo-controlled study. Eur Heart J. (2021) 42:178–88. 10.1093/eurheartj/ehaa898 - DOI - PMC - PubMed

Publication types